CATALOGO DEI PRODOTTI DELLA RICERCA

Maggino, Laura
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.480
EU - Europa 3.451
AS - Asia 2.621
SA - Sud America 344
AF - Africa 89
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 4
Totale 9.998
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.405
RU - Federazione Russa 1.510
SG - Singapore 1.059
CN - Cina 781
GB - Regno Unito 515
IT - Italia 351
BR - Brasile 260
HK - Hong Kong 235
DE - Germania 233
VN - Vietnam 221
FR - Francia 207
IE - Irlanda 190
SE - Svezia 168
KR - Corea 83
FI - Finlandia 82
IN - India 49
UA - Ucraina 47
JP - Giappone 44
CA - Canada 39
AR - Argentina 34
NL - Olanda 34
BD - Bangladesh 26
MX - Messico 23
TR - Turchia 21
PL - Polonia 20
NG - Nigeria 19
ID - Indonesia 18
BE - Belgio 15
ES - Italia 14
IQ - Iraq 12
ZA - Sudafrica 12
DZ - Algeria 11
TG - Togo 11
EC - Ecuador 10
AT - Austria 9
SA - Arabia Saudita 9
AU - Australia 8
BJ - Benin 8
CL - Cile 8
UZ - Uzbekistan 8
CO - Colombia 7
CZ - Repubblica Ceca 7
MA - Marocco 7
PE - Perù 7
PY - Paraguay 7
AL - Albania 6
KE - Kenya 6
PH - Filippine 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
GR - Grecia 5
IL - Israele 5
JO - Giordania 5
AZ - Azerbaigian 4
HU - Ungheria 4
JM - Giamaica 4
KG - Kirghizistan 4
MY - Malesia 4
NO - Norvegia 4
PK - Pakistan 4
PT - Portogallo 4
RO - Romania 4
TN - Tunisia 4
CH - Svizzera 3
EG - Egitto 3
EU - Europa 3
LT - Lituania 3
LV - Lettonia 3
UG - Uganda 3
DK - Danimarca 2
IR - Iran 2
KZ - Kazakistan 2
NP - Nepal 2
OM - Oman 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GF - Guiana Francese 1
GH - Ghana 1
GY - Guiana 1
HN - Honduras 1
IS - Islanda 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
Totale 9.986
Salva come PNG Salva come JPEG
Città #
Singapore 536
Moscow 515
Ashburn 487
Southend 438
Chandler 418
San Jose 338
Dallas 336
Hong Kong 226
Dublin 186
Verona 180
Beijing 174
Jacksonville 153
The Dalles 143
Woodbridge 111
Ho Chi Minh City 79
Munich 73
Los Angeles 66
Lawrence 65
Princeton 65
Houston 59
New York 56
Jinan 55
Hanoi 52
Redmond 49
Wilmington 45
Nanjing 43
Helsinki 40
Shenyang 39
São Paulo 35
Tokyo 35
Redondo Beach 34
Santa Clara 33
Buffalo 30
Tianjin 29
Columbus 28
Orem 27
Ann Arbor 24
Haikou 24
Redwood City 23
Hangzhou 22
Frankfurt am Main 21
Milan 20
Changsha 19
Council Bluffs 19
Hebei 19
Ningbo 19
Sindelfingen 19
London 18
Montreal 18
Nanchang 18
Seattle 18
Turku 18
Abuja 17
Falkenstein 16
Warsaw 16
Atlanta 15
Brussels 15
Rio de Janeiro 15
Amsterdam 14
Brooklyn 14
Chennai 14
Denver 14
Washington 14
Nuremberg 13
Toronto 13
Zhengzhou 13
Fairfield 12
Lomé 11
Norwalk 11
Taiyuan 11
Taizhou 11
Chicago 10
Fuzhou 10
Haiphong 10
Mexico City 10
Paris 10
Belo Horizonte 9
Jakarta 9
Johannesburg 9
Lancaster 9
Lappeenranta 9
Mumbai 9
San Francisco 9
Stockholm 9
Cotonou 8
Falls Church 8
Genoa 8
Tashkent 8
Baghdad 7
Istanbul 7
Manchester 7
Miami 7
Phoenix 7
Poplar 7
Ankara 6
Boston 6
Curitiba 6
Des Moines 6
Dongguan 6
Guangzhou 6
Totale 6.088
Salva come PNG Salva come JPEG
Nome #
Unraveling the role of lymph node metastasis in PDAC and dCCA progression 237
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma 232
Pancreaticoduodenectomy in patients ≥ 75 years of age: Are there any differences with other age ranges in oncological and surgical outcomes? Results from a tertiary referral center 217
Downstaging in Stage IV Pancreatic Cancer: A New Population Eligible for Surgery? 212
Decoding Grade B Pancreatic Fistula: A Clinical and Economical Analysis and Subclassification Proposal 204
A Pretreatment Prognostic Score to Stratify Survival in Pancreatic Cancer 190
Results of a surveillance protocol for pancreatic BD-IPMNs 185
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells 183
A dynamic analysis of empirical survival outcomes after pancreatectomy for pancreatic ductal adenocarcinoma 183
An unforeseeable adverse event during ERCP 179
Pancreatectomy with venous resection for pT3 head adenocarcinoma: Perioperative outcomes, recurrence pattern and prognostic implications of histologically confirmed vascular infiltration 175
Analysis and proceeding to full publication of abstracts presented at the Pancreas Club annual meeting 175
Distal pancreatectomy associated with multivisceral resection: results from a single centre experience 173
Screening/surveillance programs for pancreatic cancer in familial high-risk individuals: A systematic review and proportion meta-analysis of screening results 173
Does Size Matter in Pancreatic Cancer?: Reappraisal of Tumour Dimension as a Predictor of Outcome Beyond the TNM 168
Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreas 166
International Validation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) TNM Staging System in Patients With Resected Pancreatic Cancer 157
ASO Visual Abstract: Importance of Nodal Metastases Location in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: Results from a Prospective Lymphadenectomy Protocol 157
Risk Factors and Mitigation Strategies for Pancreatic Fistula After Distal Pancreatectomy: Analysis of 2026 Resections From the International, Multi-institutional Distal Pancreatectomy Study Group 154
Does the surgical waiting list affect pathological and survival outcome in resectable pancreatic ductal adenocarcinoma? 154
Assessment of a complication risk score and study of complication profile in laparoscopic distal pancreatectomy 151
ASO Author Reflections: Does Site Matter? Impact of Tumor Location on Pathologic Characteristics, Recurrence, and Survival of Resected Pancreatic Ductal Adenocarcinoma 150
Over 700 Whipples for Pancreaticobiliary Malignancies: Postoperative Morbidity Is an Additional Negative Prognostic Factor for Distal Bile Duct Cancer 149
Core Set of Patient-reported Outcomes in Pancreatic Cancer (COPRAC) An International Delphi Study Among Patients and Health Care Providers 149
Long-term Outcomes After Surgical Resection of Pancreatic Metastases from Renal Clear-Cell Carcinoma 149
CA19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma 145
Reappraisal of Nodal Staging and Study of Lymph Node Station Involvement in Pancreaticoduodenectomy with the Standard International Study Group of Pancreatic Surgery Definition of Lymphadenectomy for Cancer 143
Assessing the influence of experience in pancreatic surgery: a risk-adjusted analysis using the American College of Surgeons NSQIP database 142
Pancreatic Adenocarcinoma 141
Reappraisal of nodal staging and study of lymph node station involvement in distal pancreatectomy for body-tail pancreatic ductal adenocarcinoma 141
ASO Visual Abstract: Ca 19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma 136
Solid pseudopapillary tumors of the pancreas: Specific pathological features predict the likelihood of postoperative recurrence 136
Neoadjuvant Therapy Versus Upfront Resection for Pancreatic Cancer: The Actual Spectrum and Clinical Burden of Postoperative Complications 136
Defining the practice of distal pancreatectomy around the world 135
Verona Evidence-Based Meeting (EBM) 2020 on Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: Meeting Report 132
Pancreatectomy with Para-Aortic Lymph Node Dissection for Pancreatic Head Adenocarcinoma: Pattern of Nodal Metastasis Spread and Analysis of Prognostic Factors 132
The Sequential Radiographic Effects of Preoperative Chemotherapy and (Chemo)Radiation on Tumor Anatomy in Patients with Localized Pancreatic Cancer 132
The tumour immune microenvironment and microbiome of pancreatic intraductal papillary mucinous neoplasms 130
Serous cystic neoplasm of the pancreas: a multinational study of 2622 patients under the auspices of the International Association of Pancreatology and European Pancreatic Club (European Study Group on Cystic Tumors of the Pancreas) 130
Respect - A multicenter retrospective study on preoperative chemotherapy in locally advanced and borderline resectable pancreatic cancer 129
Defining the Safety Profile for Performing Pancreatoduodenectomy in the Setting of Hyperbilirubinemia 128
Identification of an Optimal Cut-off for Drain Fluid Amylase on Postoperative Day 1 for Predicting Clinically Relevant Fistula After Distal Pancreatectomy: A Multi-institutional Analysis and External Validation 126
Decision-Making for the Management of Cystic Lesions of the Pancreas: How Satisfied Are Patients with Surgery? 124
Synchronous superior mesenteric-portal vein resection during pancreatectomy for T3 head adenocarcinoma: Perioperative outcomes and prognostic implications of histologically confirmed venous infiltration 122
ASO Author Reflection: Location of Nodal Metastases in Pancreatoduodenectomy for Cancer: Which Station Matters? 118
Importance of Nodal Metastases Location in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: Results from a Prospective, Lymphadenectomy Protocol 115
Guidelines on Pancreatic Cystic Neoplasms: Major Inconsistencies With Available Evidence and Clinical Practice- Results From an International Survey 114
Synchronous resections of hepatic oligometastatic pancreatic cancer: Disputing a principle in a time of safe pancreatic operations in a retrospective multicenter analysis 111
Evaluation of the MDACC clinical classification system for pancreatic cancer patients in an European multicenter cohort 108
Pathological staging in postneoadjuvant pancreatectomy for pancreatic cancer: implications for adjuvant therapy 106
Pancreatogastrostomy Vs. Pancreatojejunostomy: a Risk-Stratified Analysis of 5316 Pancreatoduodenectomies 103
Corrigendum: Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected after neoadjuvant therapy: a retrospective, multicenter analysis 101
ASO Author Reflections: Recurrence Following Post-neoadjuvant Pancreatectomy: How Can We Do Better? 98
Number of Examined Lymph Nodes and Nodal Status Assessment in Distal Pancreatectomy for Body/Tail Ductal Adenocarcinoma 96
The Beneficial Effects of Minimizing Blood Loss in Pancreatoduodenectomy 95
Evolving the Paradigm of Early Drain Removal Following Pancreatoduodenectomy 94
Revision of Pancreatic Neck Margins Based on Intraoperative Frozen Section Analysis Is Associated With Improved Survival in Patients Undergoing Pancreatectomy for Ductal Adenocarcinoma 94
ASO Visual Abstract: FOLFIRINOX or Gemcitabine Based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-Institutional, Patient-Level Meta-Analysis and Systematic Review 94
Extended Experience with a Dynamic, Data-Driven Selective Drain Management Protocol in Pancreaticoduodenectomy: Progressive Risk Stratification for Better Practice 93
Does Site Matter? Impact of Tumor Location on Pathologic Characteristics, Recurrence, and Survival of Resected Pancreatic Ductal Adenocarcinoma 90
Reappraising the Concept of Conditional Survival After Pancreatectomy for Ductal Adenocarcinoma: A Bi-institutional Analysis 89
Identification of Patients for Adjuvant Therapy After Resection of Carcinoma of the Extrahepatic Bile Ducts: A Propensity Score-Matched Analysis 89
Intraductal Papillary Mucinous Neoplasm Around the World 87
Surgical experience and the practice of pancreatoduodenectomy 87
Response to: Managing the High-risk Pancreatic Anastomosis 86
The Influence of Intraoperative Blood Loss on Fistula Development Following Pancreatoduodenectomy 85
Trends in practice patterns and outcomes: A decade of sarcoma care in the United States 85
The Fistula Risk Score Catalog: Toward Precision Medicine for Pancreatic Fistula After Pancreatoduodenectomy 83
Pancreatic Head Resection Following Roux-en-Y Gastric Bypass: Operative Considerations and Outcomes 78
Pancreatic ductal adenocarcinoma: time for a neoadjuvant revolution? 78
Impact of Operative Time on Outcomes after Pancreatic Resection: A Risk-Adjusted Analysis Using the American College of Surgeons NSQIP Database 77
Response to Comment on "Reappraising the Concept of Conditional Survival After Pancreatectomy for Ductal Adenocarcinoma" 76
Reassessment of the Optimal Number of Examined Lymph Nodes in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma 75
FOLFIRINOX or Gemcitabine-based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-institutional, Patient-Level, Meta-analysis and Systematic Review 70
Reappraisal of a 2-Cm Cut-Off Size for the Management of Cystic Pancreatic Neuroendocrine Neoplasms: A Multicenter International Study 70
Response to: "Risk-adjusted Outcomes of Clinically Relevant Pancreatic Fistula Following Pancreatoduodenectomy: A Model for Performance Evaluation" 69
Forecasting surgical costs: Towards informed financial consent and financial risk reduction 68
Pasireotide for the Prevention of Postoperative Pancreatic Fistula: Time to Curb the Enthusiasm? 66
Taking Theory to Practice: Quality Improvement for Pancreaticoduodenectomy and Development and Integration of the Fistula Risk Score 62
Outcomes of rescue procedures in the management of locally recurrent ampullary tumors: A Pancreas 2000/EPC study 61
Totale 10.133
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.925
article - articoli 34.766
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 728
patent - brevetti 0
selected - selezionate 0
volume - volumi 431
Totale 71.850
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202177 0 0 0 0 0 0 0 0 0 16 44 17
2021/2022459 45 120 10 24 10 10 12 33 29 16 32 118
2022/20231.168 71 139 102 195 100 300 30 79 106 11 22 13
2023/2024639 26 64 64 65 67 115 54 42 14 18 79 31
2024/20251.623 81 90 54 251 79 34 98 114 229 118 146 329
2025/20264.698 365 218 343 742 1.304 321 447 278 386 294 0 0
Totale 10.133